Gene · 3205
Papers4,255
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 4,255
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Detection of a Novel MSI2-C17orf64 Transcript in a Patient with Aggressive Adenocarcinoma of the Gastroesophageal Junction: A Case Report. | Genes (Basel) | 2023 | 37107676 | PubTator, text mining | PubMed |
| Understanding the Role of Chemerin in the Pathophysiology of Pre-Eclampsia. | Antioxidants (Basel) | 2023 | 37107205 | PubTator, text mining | PubMed |
| The EGR3 regulome of infant KMT2A-r acute lymphoblastic leukemia identifies differential expression of B-lineage genes predictive for outcome. | Leukemia | 2023 | 37100882 | PubTator, text mining | PubMed |
| Association of frequent hypermethylation with high grade histological subtype in lung adenocarcinoma. | Cancer Sci | 2023 | 37082886 | PubTator, text mining | PubMed |
| The expanding universe of NUTM1 fusions in pediatric cancer. | Clin Transl Sci | 2023 | 37082775 | PubTator, text mining | PubMed |
| CircRBM33 promotes migration, invasion and mediates osimertinib resistance in non-small cell lung cancer cell line. | Ann Transl Med | 2023 | 37082696 | PubTator, text mining | PubMed |
| PES1 is a biomarker of head and neck squamous cell carcinoma and is associated with the tumor microenvironment. | Cancer Med | 2023 | 37076985 | PubTator, text mining | PubMed |
| A robust reprogramming strategy for generating hepatocyte-like cells usable in pharmaco-toxicological studies. | Stem Cell Res Ther | 2023 | 37072803 | PubTator, text mining | PubMed |
| Novel insights into the multifaceted roles of m6A-modified LncRNAs in cancers: biological functions and therapeutic applications. | Biomark Res | 2023 | 37069649 | PubTator, text mining | PubMed |
| Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial. | Nat Med | 2023 | 37069359 | PubTator, text mining | PubMed |
| Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia. | Blood Cancer Discov | 2023 | 37067914 | PubTator, text mining | PubMed |
| Infantile B-lymphoblastic leukemia: a case series and review of the literature. | J Int Med Res | 2023 | 37066443 | PubTator, text mining | PubMed |
| Pyroptosis-triggered pathogenesis: New insights on antiphospholipid syndrome. | Front Immunol | 2023 | 37063905 | PubTator, text mining | PubMed |
| Research hotspots and trends of microRNAs in intervertebral disc degeneration: a comprehensive bibliometric analysis. | J Orthop Surg Res | 2023 | 37061725 | PubTator, text mining | PubMed |
| Oncogenic drivers dictate immune control of acute myeloid leukemia. | Nat Commun | 2023 | 37059710 | PubTator, text mining | PubMed |
| Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1. | Blood Cancer J | 2023 | 37055414 | PubTator, text mining | PubMed |
| Menin-MLL1 Interaction Small Molecule Inhibitors: A Potential Therapeutic Strategy for Leukemia and Cancers. | Molecules | 2023 | 37049787 | PubTator, text mining | PubMed |
| Exosomal miRNAs in the Tumor Microenvironment of Multiple Myeloma. | Cells | 2023 | 37048103 | PubTator, text mining | PubMed |
| The Small RNA Landscape in NSCLC: Current Therapeutic Applications and Progresses. | Int J Mol Sci | 2023 | 37047090 | PubTator, text mining | PubMed |
| HOXA9 gene promotor methylation and copy number variation of SOX2 and HV2 genes in cell free DNA: A potential diagnostic panel for non-small cell lung cancer. | BMC Cancer | 2023 | 37038139 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3205/papers?page=22